Nicolas Azzopardi
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
-
- Biosimilars and Bioanalytical Methods
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 10
- Oncology 7
- Colorectal Cancer Treatments and Studies 5
- HER2/EGFR in Cancer Research 2
- Co-authors
- Gilles Paintaud (26 shared papers)David Ternant (16 shared papers)Valérie Gouilleux‐Gruart (10 shared papers)Hervé Watier (7 shared papers)Thierry Lecomte (7 shared papers)Nathalie Heuzé‐Vourc'h (5 shared papers)Céline Desvignes (7 shared papers)Théodora Bejan‐Angoulvant (4 shared papers)
In The Last Decade
Nicolas Azzopardi
31 papers receiving 793 citations
Peers
Comparison fields: 5 of 62
- Radiology, Nuclear Medicine and Imaging 204
- Immunology 128
- Pulmonary and Respiratory Medicine 175
- Genetics 47
- Oncology 98
Countries citing papers authored by Nicolas Azzopardi
This map shows the geographic impact of Nicolas Azzopardi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Azzopardi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Azzopardi more than expected).
Fields of papers citing papers by Nicolas Azzopardi
This network shows the impact of papers produced by Nicolas Azzopardi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Azzopardi. The network helps show where Nicolas Azzopardi may publish in the future.
Co-authors
The 25 scholars most cited alongside Nicolas Azzopardi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 99 | |
| 2 | 2011 | 87 | |
| 3 | 2011 | 66 | |
| 4 | 2013 | 61 | |
| 5 | 2009 | 57 | |
| 6 | 2016 | 57 | |
| 7 | 2015 | 39 | |
| 8 | 2018 | 35 | |
| 9 | 2014 | 31 | |
| 10 | 2023 | 30 | |
| 11 | 2019 | 27 | |
| 12 | 2016 | 26 | |
| 13 | 2016 | 22 | |
| 14 | 2019 | 20 | |
| 15 | 2017 | 19 | |
| 16 | 2015 | 18 | |
| 17 | 2008 | 16 | |
| 18 | 2019 | 15 | |
| 19 | 2020 | 15 | |
| 20 | 2021 | 15 |
About Nicolas Azzopardi
Nicolas Azzopardi is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology, Transplantation, Genetics and Pulmonary and Respiratory Medicine, having authored 33 papers that have together received 816 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (10 papers), Colorectal Cancer Treatments and Studies (5 papers), Inhalation and Respiratory Drug Delivery (4 papers), Renal Transplantation Outcomes and Treatments (3 papers), HER2/EGFR in Cancer Research (2 papers), Autism Spectrum Disorder Research (2 papers), Rheumatoid Arthritis Research and Therapies (2 papers) and Vascular Anomalies and Treatments (2 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (204 citations), Immunology (128 citations), Pulmonary and Respiratory Medicine (175 citations), Genetics (47 citations) and Oncology (98 citations). Nicolas Azzopardi has collaborated with scholars based in France, Belgium and India. Frequent co-authors include Gilles Paintaud, David Ternant, Valérie Gouilleux‐Gruart, Hervé Watier, Thierry Lecomte, Nathalie Heuzé‐Vourc'h, Céline Desvignes, Théodora Bejan‐Angoulvant, Friedrich Piller and Erick C. Gamelin. Their work appears in journals such as Clinical Pharmacokinetics, mAbs, British Journal of Clinical Pharmacology, Journal of Controlled Release and Therapeutic Drug Monitoring.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.